skin

Pharmalot By Ed Silverman

Pharmalittle: Gilead faces partial clinical hold on blood cancer drug; Rhode Island agrees to opioid deal with wholesalers

Health Tech By Mario Aguilar

Akili, maker of prescription video game to treat ADHD, to go public via SPAC

Biotech By Adam Feuerstein

Future of Gilead blood cancer drug is clouded after studies are stopped due to safety issue

First Opinion Podcast By Patrick Skerrett

Listen: Burnout at the bedside is causing a crisis in nursing

First Opinion By Amanda Joy Calhoun

How Black hair racism affects mental health care

Health By Helen Branswell

Why Hong Kong may become a living laboratory in search for Covid-19 answers

Health Tech By Mario Aguilar

A former FDA official on making the jump to health tech startups

Pharmalot By Ed Silverman

Insufficient progress is being made in reporting clinical trial results in the U.S.